REFERENCES
- Braunwald E. Shattuck lecture – cardiovascular medi- cine at the turn of the millennium: triumphs, concern, and opportunities. N Engl J Med 1997;337:1360–9
- American Heart Association. Heart and Stroke Facts: 1995 Statistical Supplement. Dallas, TX: American Heart Association, 1994
- Williams GH, Lilly LS, Seely EW. Thyroid disease. In Braunwald E, ed. Heart Disease, 5th edn. Philadelphia: W.B. Saunders, 1999:1890–3
- Sarrafzadegan N, Najafian J. Priorities in cardiovascular prevention in Iran. Iranian Heart J 1998; 1(Suppl 1): 131–6
- Farley TM, Meirik O, Poulter NR, Chang CL, Marmot MG. Oral contraceptives and thrombotic diseases: impact of new epidemiological studies. Contra- ception 1996;54:193–8
- Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case–control study. Contraception 1998;57:291–301
- Diab KM, Zaki MM. Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CT-380A. J Obstet Gynecol Res 2000;26:17–26
- Winkler UH. Blood coagulation and oral contracep- tives. A critical review. Contraception 1998;57:203–9
- World Health Organization. Cardiovascular Disease and Steroid Contraception 1998, Scientific Report No. 877
- Azizi F, Rahmani M, Habib E, et al. Tehran Lipid and Glucose Study: rationale and design. Cardiovasc Dis Prevention 2000;3:242–7
- Cerel-Suhl SL, Yeager BF. Update on oral contra- ceptive pills. Am Fam Physician 1999;60:2073–84
- Petitti DB, Wingerd J, Pellegrin F, et al. Risk of vascular disease in women, smoking, oral contraceptives, non- contraceptive estrogens, and other factors. J Am Med Assoc 1979;242:1150–4
- La Vecchia C, Franceschi S, Decarli A, et al. Risk factors for myocardial infarction in young women. Am J Epidemiol 1987;125:825–43
- Croft P, Hannaford PC. Risk factors for acute myo- cardial infarction in women: evidence from the Royal College of General Practitioners oral contraception study. Br Med J 1989;298:165–8
- Thorogood M, Mann J, Murphy M, et al. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case–control study. Br J Obstet Gynaecol 1991;98:1245–53
- Salonen JT. Oral contraceptives, smoking and risk of myocardial infarction in young women. A longitudinal population study in eastern Finland. Acta Med Scand 1982;212:141–4
- Shapiro S, Slone D, Rosenberg L, et al. Oral contra- ceptive use in relation to myocardial infarction. Lancet 1979;1:743–7
- Rosenberg L, Hennekens CH, Rosner B, et al. Oral contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol 1980;111:59–66
- Rosenberg L, Palmer JR, Lesko SM, et al. Oral contra- cepive use and the risk of myocardial infarction. Am J Epidemiol 1990;131:1009–16
- Kuhl H, Marz W, Jung-Hoffmann C, Weber J, Siekmeier R, Gross W. Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transi- tory decrease in Lp(a) levels. Contraception 1993;47:69–83
- Karjalainen A, Heikkinen J, Savolainen MJ, Backstorm AC, Salinto M, Kesaniemi YA. Metabolic changes induced by peroral estrogen and transdermal oestradiol gel therapy. Br J Obstet Gynaecol 1997;104:38–43
- Winkler UH, Holscher T, Schulte H, Zierleyn JP, Collet W, Schindler AE. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the haemostatic system. Gynecol Endocrinol 1996;10:265–71
- Kasule J, Mbizvo M, Makuyana D, Mosona D. Evalua- tion of a combined oral contraceptive pill in black Zimbabwean women. Cent Afr J Med 1991;37:403–9
- Wiseman RA. Absence of correlation between oral contraceptive usage and cardiovascular mortality. Int J Fertil 1984;29:198–208
- Hirvonen E, Idanpaan Heikkila J. Cardiovascular death among women under 40 years of age using low- estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984. Am J Obstet Gynecol 1990; 163:281–4
- Thorogood M, Vessey MP. An epidemiologic survey of cardiovascular disease in women taking oral contra- ceptives. Am J Obstet Gynecol 1990;163:274–81
- Stergachis A. Epidemiology of the noncontraceptive effects of oral contraceptives. Am J Obstet Gynecol 1992; 167:1165–70
- Thorneycroft IH. Oral contraceptives and myocardial infarction. Am J Obstet Gynecol 1990;163:1393–7